Innovating Works

HistoGeneX N.V.

Desconocido
MOGLYNET: Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabiliz... HistoGeneX N.V. participó en un H2020: H2020-MSCA-ITN-2015 The mission of MoGlyNet is to define a joint doctorate educational training model in Drug Discovery and Development where Academia and Indus...
2015-07-28 - 2019-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.